Reward deficiency syndrome: genetic aspects of behavioral disorders.

The dopaminergic and opioidergic reward pathways of the brain are critical for survival since they provide the pleasure drives for eating, love and reproduction; these are called 'natural rewards' and involve the release of dopamine in the nucleus accumbens and frontal lobes. However, the same release of dopamine and production of sensations of pleasure can be produced by 'unnatural rewards' such as alcohol, cocaine, methamphetamine, heroin, nicotine, marijuana, and other drugs, and by compulsive activities such as gambling, eating, and sex, and by risk taking behaviors. Since only a minority of individuals become addicted to these compounds or behaviors, it is reasonable to ask what factors distinguish those who do become addicted from those who do not. It has usually been assumed that these behaviors are entirely voluntary and that environmental factors play the major role; however, since all of these behaviors have a significant genetic component, the presence of one or more variant genes presumably act as risk factors for these behaviors. Since the primary neurotransmitter of the reward pathway is dopamine, genes for dopamine synthesis, degradation, receptors, and transporters are reasonable candidates. However, serotonin, norepinephrine, GABA, opioid, and cannabinoid neurons all modify dopamine metabolism and dopamine neurons. We have proposed that defects in various combinations of the genes for these neurotransmitters result in a Reward Deficiency Syndrome (RDS) and that such individuals are at risk for abuse of the unnatural rewards. Because of its importance, the gene for the [figure: see text] dopamine D2 receptor was a major candidate gene. Studies in the past decade have shown that in various subject groups the Taq I A1 allele of the DRD2 gene is associated with alcoholism, drug abuse, smoking, obesity, compulsive gambling, and several personality traits. A range of other dopamine, opioid, cannabinoid, norepinephrine, and related genes have since been added to the list. Like other behavioral disorders, these are polygenically inherited and each gene accounts for only a small per cent of the variance. Techniques such as the Multivariate Analysis of Associations, which simultaneously examine the contribution of multiple genes, hold promise for understanding the genetic make up of polygenic disorders.

[1]  J. Halikas,et al.  Effects of regular marijuana use on sexual performance. , 1982, Journal of psychoactive drugs.

[2]  M. Gill,et al.  Mapping susceptibility loci in attention deficit hyperactivity disorder: preferential transmission of parental alleles at DAT1, DBH and DRD5 to affected children , 1999, Molecular Psychiatry.

[3]  R. D. Hunt,et al.  The Contribution of α2-Noradrenergic Mechanisms to Prefrontal Cortical Cognitive Function: Potential Significance for Attention-Deficit Hyperactivity Disorder , 1996 .

[4]  D. Grandy,et al.  D2 dopamine receptor gene and obesity. , 1994, The International journal of eating disorders.

[5]  S. Steinhauer,et al.  P300 amplitude decrements in children from families of alcoholic female probands , 1995, Biological Psychiatry.

[6]  M Laruelle,et al.  D2 receptors binding potential is not affected by Taq1 polymorphism at the D2 receptor gene , 1998, Molecular Psychiatry.

[7]  J. Buxbaum,et al.  Linkage disequilibrium between an allele at the dopamine D4 receptor locus and Tourette syndrome, by the transmission-disequilibrium test. , 1996, American journal of human genetics.

[8]  E. Dawson Identification of a highly polymorphic triplet repeat marker for the brain cannabinoid receptor gene: Use in linkage and association studies of schizophrenia , 1995, Schizophrenia Research.

[9]  D. Saccuzzo,et al.  Impaired speed of visual information processing in marijuana intoxication. , 1981, The American journal of psychiatry.

[10]  N Risch,et al.  The A1 allele at the D2 dopamine receptor gene and alcoholism. A reappraisal. , 1993, JAMA.

[11]  R. Hare Performance of psychopaths on cognitive tasks related to frontal lobe function. , 1984, Journal of abnormal psychology.

[12]  C. R. Cloninger,et al.  A psychobiological model of temperament and character. , 1993, Archives of general psychiatry.

[13]  R. Tarter,et al.  Differentiation of alcoholics. Childhood history of minimal brain dysfunction, family history, and drinking pattern. , 1977, Archives of general psychiatry.

[14]  K. Merikangas,et al.  Familial transmission of substance use disorders. , 1998, Archives of general psychiatry.

[15]  C. Bowden,et al.  Dopamine-beta-hydroxylase in behaviorally disturbed youth Relationship between teacher and parent ratings , 1993, Biological Psychiatry.

[16]  D. Comings,et al.  Correlation of length of VNTR alleles at the X-linked MAOA gene and phenotypic effect in Tourette syndrome and drug abuse , 1998, Molecular Psychiatry.

[17]  D. Comings,et al.  Additive effect of three noradrenergic genes (ADRA2A, ADRA2C, DBH) on attention‐deficit hyperactivity disorder and learning disabilities in Tourette syndrome subjects , 1999, Clinical genetics.

[18]  D. Gibson,et al.  Isolation and structure of a brain constituent that binds to the cannabinoid receptor. , 1992, Science.

[19]  W. Fratta,et al.  Determination of methionine enkephalin in discrete regions of rat brain , 1977, Brain Research.

[20]  L. Hollister,et al.  Delta‐8‐ and delta‐9‐tetrahydrocannabinol; Comparison in man by oral and intravenous administration , 1973, Clinical pharmacology and therapeutics.

[21]  D. Comings Input from Our Readers , 1999, CNS Spectrums.

[22]  G. Vaillant Empirical studies of ego mechanisms of defense , 1986 .

[23]  D. Comings,et al.  Polygenic inheritance of Tourette syndrome, stuttering, attention deficit hyperactivity, conduct, and oppositional defiant disorder: the additive and subtractive effect of the three dopaminergic genes--DRD2, D beta H, and DAT1. , 1996, American journal of medical genetics.

[24]  C. Robert Cloninger,et al.  Psychopathology in children of alcoholic and antisocial parents. , 1988, Alcoholism, clinical and experimental research.

[25]  D. Comings,et al.  The dopamine D2 receptor (DRD2) as a major gene in obesity and height. , 1993, Biochemical medicine and metabolic biology.

[26]  J. Mattes The role of frontal lobe dysfunction in childhood hyperkinesis. , 1980, Comprehensive psychiatry.

[27]  R. Cadoret,et al.  Genetic and environmental factors in alcohol abuse and antisocial personality. , 1987, Journal of studies on alcohol.

[28]  L. L. Miller Cannabis and the brain with special reference to the limbic system. , 1978, Advances in the biosciences.

[29]  N Risch,et al.  The Future of Genetic Studies of Complex Human Diseases , 1996, Science.

[30]  M. Gill,et al.  Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism , 1997, Molecular Psychiatry.

[31]  H. V. Van Tol,et al.  Modulation of Intracellular Cyclic AMP Levels by Different Human Dopamine D4 Receptor Variants , 1995, Journal of neurochemistry.

[32]  J O Rinne,et al.  The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers , 1998, Molecular Psychiatry.

[33]  D. Comings,et al.  Association of the dopamine transporter gene (DAT1) with poor methylphenidate response. , 1999, Journal of the American Academy of Child and Adolescent Psychiatry.

[34]  Allelic association of human dopamine D2 receptor gene in alcoholism. , 1990 .

[35]  L. Oreland,et al.  Low platelet monoamine oxidase activity in human alcoholics. , 1977, Medical biology.

[36]  K. Kendler,et al.  Genetic and environmental contributions to alcohol abuse and dependence in a population-based sample of male twins. , 1999, The American journal of psychiatry.

[37]  Dragan M. Svrakic,et al.  The Tridimensional Personality Questionnaire: U.S. Normative Data , 1991, Psychological reports.

[38]  S. T. Mason,et al.  Noradrenaline and selective attention: a review of the model and the evidence. , 1980, Life sciences.

[39]  Comings De,et al.  Tourette's syndrome and attention-deficit hyperactivity disorder: evidence for a genetic relationship. , 1993 .

[40]  M. Nelen,et al.  Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A. , 1993, Science.

[41]  M. Davis,et al.  Naltrexone blocks the post-shock increase of ethanol consumption. , 1986, Life sciences.

[42]  R. Mechoulam,et al.  Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish , 1964 .

[43]  P. Seeman,et al.  Multiple dopamine D4 receptor variants in the human population , 1992, Nature.

[44]  A. von Knorring,et al.  Platelet monoamine oxidase activity in type 1 and type 2 alcoholism. , 1991, Alcohol and alcoholism.

[45]  C. Robert Cloninger,et al.  Childhood personality predicts alcohol abuse in young adults. , 1988, Alcoholism, clinical and experimental research.

[46]  D. Yurgelun-Todd,et al.  The residual cognitive effects of heavy marijuana use in college students. , 1996, JAMA.

[47]  R. Mark Wightman,et al.  Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter , 1996, Nature.

[48]  J. Lowinson,et al.  Conditioned place preference induced by delta 9-tetrahydrocannabinol: comparison with cocaine, morphine, and food reward. , 1995, Life sciences.

[49]  M. Spitz,et al.  Case-control study of the D2 dopamine receptor gene and smoking status in lung cancer patients. , 1998, Journal of the National Cancer Institute.

[50]  D. Bylund,et al.  Platelet MAO activity and personality variations in normals , 1989, Psychiatry Research.

[51]  J. Axelrod,et al.  Enzymatic synthesis of anandamide, an endogenous ligand for the cannabinoid receptor, by brain membranes. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[52]  B. Diamond,et al.  Enkephalins and nigrostriatal function , 1978, Neurology.

[53]  S. Faraone,et al.  Genetic influences on DSM-III-R drug abuse and dependence: a study of 3,372 twin pairs. , 1996, American journal of medical genetics.

[54]  K. Buetow,et al.  Cloning of the human dopamine D5 receptor gene and identification of a highly polymorphic microsatellite for the DRD5 locus that shows tight linkage to the chromosome 4p reference marker RAF1P1. , 1993, Genomics.

[55]  R. Nicoll,et al.  Enkephalin blocks inhibitory pathways in the vertebrate CNS , 1980, Nature.

[56]  L. Siever,et al.  D4 dopamine-receptor (DRD4) alleles and novelty seeking in substance-dependent, personality-disorder, and control subjects. , 1997, American journal of human genetics.

[57]  A. Routtenberg The reward system of the brain. , 1978, Scientific American.

[58]  D. Grandy,et al.  The human dopamine D2 receptor gene is located on chromosome 11 at q22-q23 and identifies a TaqI RFLP. , 1989, American journal of human genetics.

[59]  R. Ebstein,et al.  Dopamine D4 receptor (D4DR) exon III polymorphism associated with the human personality trait of Novelty Seeking , 1996, Nature Genetics.

[60]  R. Cadoret,et al.  Adoption study demonstrating two genetic pathways to drug abuse. , 1995, Archives of general psychiatry.

[61]  G. Koob Drugs of abuse: anatomy, pharmacology and function of reward pathways. , 1992, Trends in pharmacological sciences.

[62]  D. Comings,et al.  The D2 Dopamine Receptor Gene as a Determinant of Reward Deficiency Syndrome , 1996, Journal of the Royal Society of Medicine.

[63]  G. Di Chiara,et al.  Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[64]  Terrie E. Moffitt,et al.  The neuropsychology of conduct disorder , 1993, Development and Psychopathology.

[65]  C. Robert Cloninger,et al.  Inheritance of risk to develop alcoholism. , 1986, NIDA research monograph.

[66]  K. Blum,et al.  Handbook of Psychiatric Genetics , 1996 .

[67]  D. Murphy,et al.  PSYCHOLOGICAL CORRELATES OF MONOAMINE OXIDASE ACTIVITY IN NORMALS , 1978, The Journal of nervous and mental disease.

[68]  D. Comings,et al.  Studies of the potential role of the dopamine D1 receptor gene in addictive behaviors , 1997, Molecular Psychiatry.

[69]  F. Bloom,et al.  Locomotor activation induced by infusion of endorphins into the ventral tegmental area: evidence for opiate-dopamine interactions. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[70]  Association of the enkephalinase gene with low amplitude P300 waves. , 1999, Neuroreport.

[71]  L. Stein,et al.  Receptor subtypes in opioid and stimulant reward. , 1992, Pharmacology & toxicology.

[72]  R. Wise,et al.  Brain dopamine and reward. , 1989, Annual review of psychology.

[73]  J. Glowinski,et al.  Selective activation of the mesocortical DA system by stress , 1976, Nature.

[74]  D. Brooks,et al.  Evidence for striatal dopamine release during a video game , 1998, Nature.

[75]  Peter Dayan,et al.  A Neural Substrate of Prediction and Reward , 1997, Science.

[76]  H. Y. Yang,et al.  Regional distribution of leu and met enkephalin in rat brain , 1977, Neuropharmacology.

[77]  S. S. St. Jeor,et al.  D2 dopamine receptor gene and cigarette smoking: a reward gene? , 1994, Medical hypotheses.

[78]  A. Cools,et al.  Stimulant effects of enkephalin microinjection into the dopaminergic A10 area , 1979, Nature.

[79]  D. Grandy,et al.  Cloning and expression of a rat D2 dopamine receptor cDNA , 1988, Nature.

[80]  Cloninger Cr A systematic method for clinical description and classification of personality variants: A proposal. , 1987 .

[81]  P Kocsis,et al.  The dopamine D2 receptor locus as a modifying gene in neuropsychiatric disorders. , 1991, JAMA.

[82]  J. Halperin,et al.  Noradrenergic mechanisms in ADHD children with and without reading disabilities: a replication and extension. , 1997, Journal of the American Academy of Child and Adolescent Psychiatry.

[83]  Thomas J. H. Chen,et al.  Increased prevalence of the Taq I A1 allele of the dopamine receptor gene (DRD2) in obesity with comorbid substance use disorder: a preliminary report. , 1996, Pharmacogenetics.

[84]  P. Wood Opioid regulation of CNS dopaminergic pathways: A review of methodology, receptor types, regional variations and species differences , 1983, Peptides.

[85]  R. Wise,et al.  A psychomotor stimulant theory of addiction. , 1987, Psychological review.

[86]  G Saucier,et al.  Studies of the 48 bp repeat polymorphism of the DRD4 gene in impulsive, compulsive, addictive behaviors: Tourette syndrome, ADHD, pathological gambling, and substance abuse. , 1999, American journal of medical genetics.

[87]  A. Alterman,et al.  Naltrexone in the treatment of alcohol dependence. , 1992, Archives of general psychiatry.

[88]  Mccracken Jt A two-part model of stimulant action on attention-deficit hyperactivity disorder in children. , 1991 .

[89]  E. Gorenstein Frontal lobe functions in psychopaths. , 1982, Journal of abnormal psychology.

[90]  M. Le Moal,et al.  Mesocorticolimbic dopaminergic network: functional and regulatory roles. , 1991, Physiological reviews.

[91]  G. Uhl,et al.  A human dopamine transporter cDNA predicts reduced glycosylation, displays a novel repetitive element and provides racially-dimorphic TaqI RFLPs. , 1992, Brain research. Molecular brain research.

[92]  E P Noble,et al.  Allelic association of the D2 dopamine receptor gene with receptor-binding characteristics in alcoholism. , 1991, Archives of general psychiatry.

[93]  W. Corrigall,et al.  Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area , 1994, Brain Research.

[94]  Thomas J. H. Chen,et al.  Dopamine D2 receptor gene variants: association and linkage studies in impulsive-addictive-compulsive behaviour. , 1995, Pharmacogenetics.

[95]  D. Comings,et al.  The clonidine patch and behavior problems. , 1990, Journal of the American Academy of Child and Adolescent Psychiatry.

[96]  Pontius Aa Dysfunction patterns analogous to frontal lobe system and caudate nucleus syndromes in some groups of minimal brain dysfunction. , 1973 .

[97]  P. Sokoloff,et al.  Dopamine-related genes and their relationships to monoamine metabolites in CSF , 1996, Biological Psychiatry.

[98]  Hunt Rd Treatment effects of oral and transdermal clonidine in relation to methylphenidate: an open pilot study in ADD-H. , 1987 .

[99]  G. Bock,et al.  The Biology of nicotine dependence , 1990 .

[100]  J. Swanson,et al.  Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder. , 1996, Molecular psychiatry.

[101]  D. Comings Why different rules are required for polygenic inheritance: lessons from studies of the DRD2 gene. , 1998, Alcohol.

[102]  L. Miller Neuropsychology of the aggressive psychopath: An integrative review , 1987 .

[103]  H. Emrich,et al.  Dopamine and the action of opiates: A reevaluation of the dopamine hypothesis of schizophrenia with special consideration of the role of endogenous opioids in the pathogenesis of schizophrenia , 1985, Biological Psychiatry.

[104]  D. Comings Polygenic inheritance and micro/minisatellites , 1998, Molecular Psychiatry.

[105]  K K Kidd,et al.  A hypervariable segment in the human dopamine receptor D4 (DRD4) gene. , 1993, Human molecular genetics.

[106]  F. Bloom,et al.  Cellular and molecular mechanisms of drug dependence. , 1988, Science.

[107]  R. Goldman,et al.  Effect of cannabinoids on neurotransmitter uptake, atpase activity and morphology of mouse brain synaptosomes , 1977 .

[108]  Camillo Ricordi,et al.  The insulin gene is transcribed in the human thymus and transcription levels correlate with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes , 1997, Nature Genetics.

[109]  A. Arnsten,et al.  Catecholamine regulation of the prefrontal cortex , 1997, Journal of psychopharmacology.

[110]  D. Comings Tourette Syndrome and Human Behavior , 1990 .

[111]  D. Comings,et al.  Cannabinoid receptor gene (CNR1): association with IV drug use , 1997, Molecular Psychiatry.

[112]  J. McCracken,et al.  Catecholamines in attention-deficit hyperactivity disorder: current perspectives. , 1996, Journal of the American Academy of Child and Adolescent Psychiatry.

[113]  H. Begleiter,et al.  Event-related brain potentials in boys at risk for alcoholism. , 1984, Science.

[114]  G. Di Chiara,et al.  Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism. , 1997, Science.

[115]  D. Comings,et al.  Molecular heterosis as the explanation for the controversy about the effect of the DRD2 gene on dopamine D2 receptor density , 1999, Molecular Psychiatry.

[116]  N J Cox,et al.  Association of attention-deficit disorder and the dopamine transporter gene. , 1995, American journal of human genetics.

[117]  H. Gurling,et al.  The D2 Dopamine Receptor Gene and Alcoholism: A Genetic Effect in the Liability for Alcoholism , 1994, Journal of the Royal Society of Medicine.

[118]  James L Olds,et al.  Positive reinforcement produced by electrical stimulation of septal area and other regions of rat brain. , 1954, Journal of comparative and physiological psychology.

[119]  B. Winblad,et al.  LOWERED MONOAMINE OXIDASE ACTIVITY IN BRAINS FROM ALCOHOLIC SUICIDES , 1975, Journal of neurochemistry.

[120]  R. D. Hunt,et al.  Clonidine benefits children with attention deficit disorder and hyperactivity: report of a double-blind placebo-crossover therapeutic trial. , 1985, Journal of the American Academy of Child Psychiatry.

[121]  T. Belin,et al.  D2 and D4 dopamine receptor polymorphisms and personality. , 1998, American journal of medical genetics.

[122]  M. Posner,et al.  The attention system of the human brain. , 1990, Annual review of neuroscience.

[123]  F. Bloom,et al.  Meta-analysis of P300 amplitude from males at risk for alcoholism , 1994 .

[124]  D. Comings,et al.  Comparison of the role of dopamine, serotonin, and noradrenaline genes in ADHD, ODD and conduct disorder: multivariate regression analysis of 20 genes , 2000, Clinical genetics.

[125]  J. Scheel-Krüger,et al.  Diethyldithiocarbamate and amphetamine stereotype behaviour , 1966, The Journal of pharmacy and pharmacology.

[126]  C. Robert Cloninger,et al.  Association of monoamine oxidase (MAO) activity with alcoholism and alcoholic subtypes. , 1993, American journal of medical genetics.

[127]  John G. Cull,et al.  REWARD DEFICIENCY SYNDROME , 1996 .

[128]  F. J. Kelly,et al.  Intelligence and Delinquency: A Reconsideration , 1963 .

[129]  M. Caron,et al.  A mouse knockout , 1996 .

[130]  D. Comings,et al.  Association between the cannabinoid receptor gene (CNR1) and the P300 event-related potential , 1997, Molecular Psychiatry.

[131]  N G Waller,et al.  The Tridimensional Personality Questionnaire: Structural Validity and Comparison with the Multidimensional Personality Questionnaire. , 1991, Multivariate behavioral research.

[132]  G. Di Chiara,et al.  Neurobiology of opiate abuse. , 1992, Trends in pharmacological sciences.

[133]  J. Wu,et al.  D2 dopamine receptor polymorphism and brain regional glucose metabolism. , 1997, American journal of medical genetics.

[134]  M. Javors,et al.  Attention deficit disorder symptoms and urine catecholamines , 1989, Psychiatry Research.

[135]  D. Comings,et al.  Molecular heterosis Implications for complex inheritance , 1997 .

[136]  J. Halperin,et al.  Plasma Catecholamine Metabolite Levels in ADHD Boys With and Without Reading Disabilities , 1993 .

[137]  P. Clarke,et al.  Mesolimbic dopamine activation--the key to nicotine reinforcement? , 2007, Ciba Foundation symposium.

[138]  A. Howlett,et al.  Pharmacology of cannabinoid receptors. , 1995, Annual review of pharmacology and toxicology.

[139]  M. Anglin,et al.  The D2 dopamine receptor gene, addiction, and personality: clinical correlates in cocaine abusers , 1996, Biological Psychiatry.